Live Breaking News & Updates on Michael Schmidt Guggenheim
Stay updated with breaking news from Michael schmidt guggenheim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exelixis, inc (EXEL) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Operator Good morning, and welcome to the ImmunoGen s First Quarter of 2021 Financial and Operating Results Conference Call. Today s conference is being recorded. At this time, I d like to turn the call over to Courtney O Konek, Senior Director of Corporate Communications and Investor Relations. Ma am, please go ahead. Courtney O Konek Senior Director of Corporate Communications and Investor Relations Good morning, and thank you for joining today s call. Earlier today, we issued a press release that includes a summary of our recent progress in first quarter 2021 financial results. This press release and a recording of this call can be found under the Investors & Media section of our website at immunogen.com. ....
Operator Good morning, ladies and gentlemen, and welcome to the Exelixis First Quarter 2021 Financial Results Conference Call. My name is Daphne, and I ll be your operator for today. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. Please proceed. Susan T. Hubbard Executive Vice President, Public Affairs and Investor Relations Thank you, Daphne, and thank you all for joining us for the Exelixis First Quarter 2021 Financial Results Conference Call. Joining me on today s call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; P.J. Haley, our Executive Vice President of Commercial; and Gisela Schwab, our Chief Medical Officer, who together will review our corporate, financial, commercial and development progress for the first quarter 2021 ended March 31, 2021. Peter ....